BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26839821)

  • 1. Validated Stability-Indicating RP-HPLC Method for the Estimation of Degradation Behaviour of Organic Peroxide and Third-Generation Synthetic Retinoids in Topical Pharmaceutical Dosage Formulation.
    Roy C; Panigrahi L; Chakrabarty J
    Sci Pharm; 2015; 83(2):321-38. PubMed ID: 26839821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form.
    Trivedi RK; Patel MC
    Sci Pharm; 2011; 79(1):97-111. PubMed ID: 21617775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Phenoxyethanol, Methylparaben, Propylparaben, Mometasone Furoate, and Tazarotene in Topical Pharmaceutical Dosage Formulation.
    Roy C; Chakrabarty J
    Sci Pharm; 2013; 81(4):951-67. PubMed ID: 24482766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of stability indicating the RP-HPLC method for the estimation of related compounds of guaifenesin in pharmaceutical dosage forms.
    Reddy SP; Babu KS; Kumar N; Sekhar YV
    Pharm Methods; 2011 Oct; 2(4):229-34. PubMed ID: 23781462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation.
    Kumar N; Sangeetha D
    Sci Pharm; 2013; 81(3):697-711. PubMed ID: 24106668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality by Design-Based Development of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Methylparaben, Propylparaben, Diethylamino Hydroxybenzoyl Hexyl Benzoate, and Octinoxate in Topical Pharmaceutical Formulation.
    Roy C; Chakrabarty J
    Sci Pharm; 2014; 82(3):519-39. PubMed ID: 25853065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Novel Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Halometasone, Fusidic Acid, Methylparaben, and Propylparaben in Topical Pharmaceutical Formulation.
    Goswami N; Gupta VR; Jogia HA
    Sci Pharm; 2013; 81(2):505-18. PubMed ID: 23833716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated Stability-indicating High-performance Liquid Chromatographic Method for Estimation of Degradation Behaviour of Eberconazole Nitrate and Mometasone Furoate in Cream Formulation.
    Sharma N; Rao SS; Vaghela B
    Indian J Pharm Sci; 2013 Jan; 75(1):76-82. PubMed ID: 23901164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Drotaverine Impurities in API and Pharmaceutical Formulation.
    Thummala VR; Tharlapu SS; Rekulapalli VK; Ivaturi MR; Nittala SR
    Sci Pharm; 2014; 82(1):99-115. PubMed ID: 24634845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, Identification, and Characterisation of Degradation Products and the Development and Validation of a Stability-Indicating Method for the Estimation of Impurities in the Tolterodine Tartrate Formulation.
    Prakash L; Himaja M; Vasudev R
    Sci Pharm; 2015; 83(1):65-83. PubMed ID: 26839802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated stability-indicating liquid chromatographic method for determination of process related impurities and degradation behavior of Irbesartan in solid oral dosage.
    Goswami N
    J Adv Pharm Technol Res; 2014 Jan; 5(1):33-40. PubMed ID: 24695518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Clindamycin Phosphate and Adapalene along with Preservatives in Topical Gel Formulations.
    Modi PB; Shah NJ
    Sci Pharm; 2014; 82(4):799-813. PubMed ID: 26171325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A validated stability-indicating liquid chromatographic method for determination of degradation impurities and diastereomers in voriconazole tablets.
    Shaikh KA; Patil AT
    Sci Pharm; 2012; 80(4):879-88. PubMed ID: 23264937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel validated stability indicating high performance liquid chromatographic method for estimation of degradation behavior of ciprofloxacin and tinidazole in solid oral dosage.
    Vaghela BK; Rao SS
    J Pharm Bioallied Sci; 2013 Oct; 5(4):298-308. PubMed ID: 24302838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of halobetasol propionate and its impurities present in topical dosage forms by stability-indicating LC method.
    Nalwade S; Reddy VR; Kulkarni D; Todamal S
    J Chromatogr Sci; 2015 Jan; 53(1):127-34. PubMed ID: 24784115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated stability-indicating LC method for the separation of enantiomer and potential impurities of Linezolid using polar organic mode.
    Satyanarayana Raju T; Vishweshwari Kutty O; Ganesh V; Yadagiri Swamy P
    J Pharm Anal; 2012 Aug; 2(4):272-278. PubMed ID: 29403753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validated specific stability-indicating RP-HPLC assay method for Ambrisentan and its related substances.
    Narayana MB; Chandrasekhar KB; Rao BM
    J Chromatogr Sci; 2014 Sep; 52(8):818-25. PubMed ID: 23926121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
    Reddy PS; Sudhakar Babu K; Kumar N
    J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.